Clopidogrel pharmacokinetics and pharmacodynamics in out-of-hospital cardiac arrest patients with acute coronary syndrome undergoing target temperature management

Resuscitation ◽  
2016 ◽  
Vol 102 ◽  
pp. 63-69 ◽  
Author(s):  
Jan Kaufmann ◽  
Ernst Wellnhofer ◽  
Helena Stockmann ◽  
Kristof Graf ◽  
Eckart Fleck ◽  
...  
2019 ◽  
Vol 63 (8) ◽  
pp. 1079-1088
Author(s):  
Toni Pätz ◽  
Katharina Stelzig ◽  
Rüdiger Pfeifer ◽  
Undine Pittl ◽  
Holger Thiele ◽  
...  

Critical Care ◽  
2020 ◽  
Vol 24 (1) ◽  
Author(s):  
Joachim Düring ◽  
Martin Annborn ◽  
Tobias Cronberg ◽  
Josef Dankiewicz ◽  
Yvan Devaux ◽  
...  

Abstract Background Arginine vasopressin has complex actions in critically ill patients, involving vasoregulatory status, plasma volume, and cortisol levels. Copeptin, a surrogate marker for arginine vasopressin, has shown promising prognostic features in small observational studies and is used clinically for early rule out of acute coronary syndrome. The objective of this study was to explore the association between early measurements of copeptin, circulatory status, and short-term survival after out-of-hospital cardiac arrest. Methods Serial blood samples were collected at 24, 48, and 72 h as part of the target temperature management at 33 °C versus 36 °C after cardiac arrest trial, an international multicenter randomized trial where unconscious survivors after out-of-hospital cardiac arrest were allocated to an intervention of 33 or 36 °C for 24 h. Primary outcome was 30-day survival with secondary endpoints circulatory cause of death and cardiovascular deterioration composite; in addition, we examined the correlation with extended the cardiovascular sequential organ failure assessment (eCvSOFA) score. Results Six hundred ninety patients were included in the analyses, of whom 203 (30.3%) developed cardiovascular deterioration within 24 h, and 273 (39.6%) died within 30 days. Copeptin measured at 24 h was found to be independently associated with 30-day survival, hazard ratio 1.17 [1.06–1.28], p = 0.001; circulatory cause of death, odds ratio 1.03 [1.01–1.04], p = 0.001; and cardiovascular deterioration composite, odds ratio of 1.05 [1.02–1.08], p < 0.001. Copeptin at 24 h was correlated with eCvSOFA score with rho 0.19 [0.12–0.27], p < 0.001. Conclusion Copeptin is an independent marker of severity of the post cardiac arrest syndrome, partially related to circulatory failure. Trial registration Clinical Trials, NCT01020916. Registered November 26, 2009.


Circulation ◽  
2015 ◽  
Vol 131 (15) ◽  
pp. 1340-1349 ◽  
Author(s):  
Gisela Lilja ◽  
Niklas Nielsen ◽  
Hans Friberg ◽  
Janneke Horn ◽  
Jesper Kjaergaard ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document